Early trials are exploring retatrutides potential applications in prevention and treatments for younger populations
How to use the product take a single dose per day, preferably one hour before exercise
GIP receptor agonism is hypothesised, based on preclinical and early clinical data, to complement GLP-1 effects on insulin secretion and may influence adipose tissue metabolism, though the precise contribution in humans remains an area of active investigation
About this article Cite this article de S, J.R., Rangel, E.B., Canani, L.H
British Journal of Anaesthesia
In addition to the original R1 formulation of 3, 7 and 14mg, there is now a more conservative R2 dosing formulation of 1.5, 4 and 9mg